2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Immunotoxins: new trials by email Literature Review of Immunotoxins trials Research Report on Immunotoxins
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LMB-2 to Treat Hairy Cell Leukemia Anti-Tac(Fv)-PE38 (LMB-2) Immunotoxin - Hairy Cell Leukemia | Phase 2 | Completed | National Cancer Institute (NCI) | 15 | 2006-05-02 | 2023-11-14 |
| Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors TP-38, TP38 - Recurrent Glioblastoma Multiforme | Phase 2 | Completed | Teva Branded Pharmaceutical Products R&D, Inc. | 56 | 2003-10-01 | 2012-01-20 |
Glioblastoma (1) · Leukemia, Hairy Cell (1)
National Cancer Institute (NCI) (1) · Teva Branded Pharmaceutical Products R&D, Inc. (1)
United States (1)